4
Changes in Ownership
AbCellera Biologics Inc. Filed Acc 0001703057-24-000004
Options or other derivatives
- Chief Financial Officer acquired 770,416 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Booth Andrew Chief Financial Officer | 2024-01-14 | Grant or award · Share option (right to buy) | +770,416 | 6,590,897 | D | ||
Loading xslF345X05/wk-form4_1705447127.xml…